Table 2.
Action potential properties.
| Cell type | AP threshold (mV) | AP peak (mV) | AP rise time (ms) | AP half-width (ms) | AHP peak (mV) |
|---|---|---|---|---|---|
| VGAT+ (targeted inhibitory, n = 74) | −33.2 ± 3.7* (VGAT−, VGLUT2+) | 63.7 ± 11.7* (VGAT−, VGLUT2+) | 0.86 ± 0.23 (VGAT−, VGLUT2+) | 3.18 ± 0.78 (VGAT−, VGLUT2+) | −20.5 ± 7.3 |
| VGAT− (putative excitatory, n = 51) | −27.2 ± 6.0* (VGAT+, VGLUT2−) | 52.8 ± 11.3 (VGAT+, VGLUT2−) | 1.11 ± 0.40 (VGAT+, VGLUT2−) | 3.90 ± 1.30 (VGAT+, VGLUT2−) | −20.9 ± 6.5 |
| VGLUT2+ (targeted excitatory, n = 39) | −27.8 ± 6.0* (VGAT+, VGLUT2−) | 49.9 ± 11.4 (VGAT+, VGLUT2−) | 1.22 ± 0.48 (VGAT+, VGLUT2−) | 3.99 ± 1.09 (VGAT+, VGLUT2−) | −18.1 ± 6.5 (VGLUT2−) |
| VGLUT2− (putative inhibitory, n = 23) | −30.2 ± 5.6* (VGAT−, VGLUT2+) | 58.7 ± 9.7 (VGAT−, VGLUT2+) | 0.80 ± 0.20 (VGAT−, VGLUT2+) | 3.06 ± 0.87 (VGAT−, VGLUT2+) | −23.9 ± 5.8 (VGLUT2+) |
Mean ± SD. Significant differences between groups denoted by *(bracketed below, p < 0.05).